Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncogenes and tumor suppressor genes

D P Carbone1

  • 1University of Texas Southwestern Medical Center, Dallas.

Hospital Practice (Office Ed.)
|June 15, 1993
PubMed
Summary

Molecular oncologists study cancer cell proliferation, focusing on oncogenes like ras and tumor suppressor genes like p53. Understanding these genetic mechanisms is key to cancer research and treatment development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA.

ESMO open·2025
Same author

Vaping, Smoking and Lung Cancer Risk.

Journal of oncology research and therapy·2024
Same author

Genomic characterization of thymic epithelial tumors in a real-world dataset.

ESMO open·2023
Same author

Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].

ESMO open·2021
Same author

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.

ESMO open·2021
Same author

Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Area of Science:

  • Molecular oncology
  • Cancer genetics

Background:

  • Cancer cell proliferation is driven by genetic alterations.
  • Dominant oncogenes, such as the ras family, promote uncontrolled cell growth via mutations.
  • Tumor suppressor genes, like p53, play a role in DNA repair and preventing cancer.

Purpose of the Study:

  • To elucidate the genetic mechanisms of cancer cell proliferation.
  • To highlight key oncogenes and tumor suppressor genes involved in cancer.

Main Methods:

  • Review of prominent oncogenes (e.g., ras family).
  • Discussion of tumor suppressor genes (e.g., p53).
  • Focus on genetic mutations and signal transduction pathways.

Main Results:

  • Ras family oncogenes are activated by point mutations, perpetuating growth signals.
  • The p53 tumor suppressor gene is implicated in DNA damage repair.

Conclusions:

  • Genetic mutations in oncogenes and tumor suppressor genes are central to cancer development.
  • Further research into these genetic mechanisms is crucial for therapeutic strategies.

Related Experiment Videos